# Lovastatin and Its ß-hydroxy Acid From Four 600 mg LipoCol Forte® Capsules Compared to That of One 20 mg Mevacor® Tablet in Healthy Subjects

> **NCT01346670** · PHASE4 · COMPLETED · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 14 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** LipoCol and Mevacor

## Key facts

- **NCT ID:** NCT01346670
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01346670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01346670, "Lovastatin and Its ß-hydroxy Acid From Four 600 mg LipoCol Forte® Capsules Compared to That of One 20 mg Mevacor® Tablet in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01346670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*